StockSelector.com
  Research, Select, & Monitor Thursday, September 24, 2020 11:30:33 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Dicerna Pharmaceuticals Inc$17.98($.87)(4.62%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Dicerna Pharmaceuticals Inc has an overall rank of 7028 out of 7770 stocks based on 6 positive rankings and 10 negative rankings.

Positive Rankings
Estimated Revenue Growth
Dicerna Pharmaceuticals Inc rank is 51
Target Prices
The average analysts' target price is $35.00 for Dicerna Pharmaceuticals Inc using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Dicerna Pharmaceuticals Inc is ranked 168.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Dicerna Pharmaceuticals Inc is ranked 266.
Low vPut/Call
Dicerna Pharmaceuticals Inc has a low Put/Call ratio of 0.16 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Dicerna Pharmaceuticals Inc is ranked 377.
10 Day Gain
Dicerna Pharmaceuticals Inc rank is 547
Highest Cash Growth
Dicerna Pharmaceuticals Inc rank is 1260
Negative Rankings
Negative Stoch Cross
Dicerna Pharmaceuticals Inc rank is 128
Price-to-Sales
Dicerna Pharmaceuticals Inc rank is 426
Negative ROE
Dicerna Pharmaceuticals Inc rank is 480
Negative Net Margin
Dicerna Pharmaceuticals Inc rank is 480
Price-to-Book
Dicerna Pharmaceuticals Inc rank is 599
High Put/Call
Dicerna Pharmaceuticals Inc has a high Put/Call ratio of 1.12 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Dicerna Pharmaceuticals Inc is ranked 658.
90 Day Loss
Dicerna Pharmaceuticals Inc rank is 815
Negative ROA
Dicerna Pharmaceuticals Inc rank is 1019
Down EPS Surprise
Dicerna Pharmaceuticals Inc missed the consensus earnings estimate when it last reported quarterly earnings.
Debt-to-Equity
Dicerna Pharmaceuticals Inc rank is 1332







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.